By Alicja Urbaniak, MSc, PhD
The Partnerships Committee recently launched a new partnership with the Indian Pharmacological Society (IPS). On behalf of the Partnerships Committee, a sub-committee consisting of Alicja Urbaniak, PhD, University of Arkansas for Medical Sciences; Adam Lauver, PhD, Michigan State University; Fadi Khasawneh, PhD, Texas A&M University; and Yurong Lai, PhD, Gilead Sciences, worked on this partnership. The partnership will kick off with a joint Focus on Pharmacology webinar, “Emerging Trends in Translational Pharmacology: From Drug Discovery to Precision Therapeutics,” on December 16, 2026, from 12 to 1 pm ET. The webinar will be chaired by Dr. Melissa Barker-Haliski, an associate professor at the University of Washington School of Pharmacy. Speakers from both societies will compare approaches to translating discoveries into patient-matched treatments. Representing ASPET, Dr. Lori Isom, Professor and Chair of Pharmacology at the University of Michigan, will present “ASO-Mediated Modulation of Poison Exons to Address Dravet Syndrome.” Representing IPS, Dr. Mukesh Navarre, Associate Dean of Research and Head of the School of Pharmaceutical Sciences at Delhi Pharmaceutical Sciences and Research University (DPSRU) in New Delhi, India, will present “Translational Cardiometabolic Pharmacology: From Molecular Targets to Precision Therapeutics.” This event is free and open to both members and non-members.
Additional activities under the broader IPS partnership are in development and will include collaborative symposia at society meetings; exchange initiatives for early-career researchers and young scientists; student mentoring and professional development programs; joint educational resources and pharmacology teaching initiatives; collaborative discussions on global health, drug discovery, and translational pharmacology; and opportunities for collaborative publications and scientific networking.
The Partnerships Committee is also pleased to co-sponsor the 2027 ASPET TOX–British Toxicology Society (BTS) Global Scholar Program. The exchange alternates annually: one year, a BTS member presents at ASPET’s annual meeting; the following year, an ASPET member presents at the BTS meeting. Participants may also visit laboratories relevant to their interests and build connections that could lead to future collaborations. Since its launch in 2025, the program has had two ASPET members (John Clarke, PhD, Washington State University in 2025 and Hartmut Jaeschke, PhD, ATS, FAASLD, University of Kansas Medical Centre in 2026) and one BTS member (Joshua Gardner, PhD, University of Liverpool in 2025) selected as BTS-ASPET Scholars. Professor Ian Copple of the University of Liverpool has been selected as the 2027 BTS-ASPET Scholar and will present at the 2027 ASPET Annual Meeting. At the 2027 ASPET Annual Meeting, a BTS member (soon to be selected by the BTS) will present. The competition for the next ASPET member to serve as the ASPET-BTS Scholar will open in late summer/early Fall 2027 for attendance at the 2028 BTS annual meeting.
Thanks to Elaine Leslie, PhD, University of Alberta, for her help with this month’s column.

